Literature DB >> 15767573

Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress.

Albena T Dinkova-Kostova1, Karen T Liby, Katherine K Stephenson, W David Holtzclaw, Xiangqun Gao, Nanjoo Suh, Charlotte Williams, Renee Risingsong, Tadashi Honda, Gordon W Gribble, Michael B Sporn, Paul Talalay.   

Abstract

A series of synthetic triterpenoid (TP) analogues of oleanolic acid are powerful inhibitors of cellular inflammatory processes such as the induction by IFN-gamma of inducible nitric oxide synthase (iNOS) and of cyclooxygenase 2 in mouse macrophages. Here, we show that these analogues are also extremely potent inducers of the phase 2 response [e.g., elevation of NAD(P)H-quinone oxidoreductase and heme oxygenase 1], which is a major protector of cells against oxidative and electrophile stress. Moreover, like previously identified phase 2 inducers, the TP analogues use the antioxidant response element-Nrf2-Keap1 signaling pathway. Thus, induction of the phase 2 response and suppression of the iNOS induction was abrogated in nrf2(-/-) and keap1(-/-) mouse embryonic fibroblasts. The high potency of TP analogues in inducing the phase 2 response and blocking inflammation depends on the presence of activated Michael reaction (enone) functions at critical positions in rings A and C. The most potent TP doubles NAD(P)H-quinone oxidoreductase in murine hepatoma cells at 0.28 nM and has an IC(50) for suppression of iNOS induction in primary mouse macrophages of 0.0035 nM. The direct interaction of this TP with thiol groups of the Keap1 sensor for inducers is demonstrated spectroscopically. The antiinflammatory and phase 2 inducer potencies of 18 TP are closely linearly correlated (r(2) = 0.91) over 6 orders of magnitude of concentration. Thus, in addition to blocking inflammation and promoting differentiation, these TP exhibit another very important protective property: the induction of the phase 2 response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767573      PMCID: PMC555528          DOI: 10.1073/pnas.0500815102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia.

Authors:  Marina Konopleva; Twee Tsao; Peter Ruvolo; Irina Stiouf; Zeev Estrov; Clinton E Leysath; Shourong Zhao; David Harris; Shirong Chang; C Ellen Jackson; Mark Munsell; Nanjoo Suh; Gordon Gribble; Tadashi Honda; W Stratford May; Michael B Sporn; Michael Andreeff
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

2.  A novel dicyanotriterpenoid, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile, active at picomolar concentrations for inhibition of nitric oxide production.

Authors:  Tadashi Honda; Yukiko Honda; Frank G Favaloro; Gordon W Gribble; Nanjoo Suh; Andrew E Place; Mara H Rendi; Michael B Sporn
Journal:  Bioorg Med Chem Lett       Date:  2002-04-08       Impact factor: 2.823

3.  Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups.

Authors:  A T Dinkova-Kostova; M A Massiah; R E Bozak; R J Hicks; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

4.  The novel triterpenoid CDDO induces apoptosis and differentiation of human osteosarcoma cells by a caspase-8 dependent mechanism.

Authors:  Y Ito; P Pandey; M B Sporn; R Datta; S Kharbanda; D Kufe
Journal:  Mol Pharmacol       Date:  2001-05       Impact factor: 4.436

5.  Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms.

Authors:  E Heiss; C Herhaus; K Klimo; H Bartsch; C Gerhäuser
Journal:  J Biol Chem       Date:  2001-06-15       Impact factor: 5.157

Review 6.  Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention.

Authors:  J D Hayes; M McMahon
Journal:  Cancer Lett       Date:  2001-12-28       Impact factor: 8.679

7.  Parallel induction of heme oxygenase-1 and chemoprotective phase 2 enzymes by electrophiles and antioxidants: regulation by upstream antioxidant-responsive elements (ARE).

Authors:  T Prestera; P Talalay; J Alam; Y I Ahn; P J Lee; A M Choi
Journal:  Mol Med       Date:  1995-11       Impact factor: 6.354

Review 8.  Therapeutic potential of dietary phase 2 enzyme inducers in ameliorating diseases that have an underlying inflammatory component.

Authors:  B H Juurlink
Journal:  Can J Physiol Pharmacol       Date:  2001-03       Impact factor: 2.273

9.  Novel synthetic oleanane and ursane triterpenoids with various enone functionalities in ring A as inhibitors of nitric oxide production in mouse macrophages.

Authors:  T Honda; G W Gribble; N Suh; H J Finlay; B V Rounds; L Bore; F G Favaloro; Y Wang; M B Sporn
Journal:  J Med Chem       Date:  2000-05-04       Impact factor: 7.446

10.  Cysteine 38 in p65/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones.

Authors:  A J García-Piñeres; V Castro; G Mora; T J Schmidt; E Strunck; H L Pahl; I Merfort
Journal:  J Biol Chem       Date:  2001-08-10       Impact factor: 5.157

View more
  195 in total

Review 1.  Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

Authors:  Magali Dumont; Michael T Lin; M Flint Beal
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  Role of peroxisome proliferator-activated receptor-gamma and its coactivator DRIP205 in cellular responses to CDDO (RTA-401) in acute myelogenous leukemia.

Authors:  Twee Tsao; Steven Kornblau; Stephen Safe; Julie C Watt; Vivian Ruvolo; Wenjing Chen; Yihua Qiu; Kevin R Coombes; Zhenlin Ju; Maen Abdelrahim; Wendy Schober; Xiaoyang Ling; Dimitris Kardassis; Colin Meyer; Aaron Schimmer; Hagop Kantarjian; Michael Andreeff; Marina Konopleva
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

3.  The triterpenoid CDDO-Me delays murine acute graft-versus-host disease with the preservation of graft-versus-tumor effects after allogeneic bone marrow transplantation.

Authors:  Minghui Li; Kai Sun; Doug Redelman; Lisbeth A Welniak; William J Murphy
Journal:  Biol Blood Marrow Transplant       Date:  2010-03-23       Impact factor: 5.742

4.  DNA methylome and transcriptome alterations and cancer prevention by triterpenoid ursolic acid in UVB-induced skin tumor in mice.

Authors:  Yuqing Yang; Ran Yin; Renyi Wu; Christina N Ramirez; Davit Sargsyan; Shanyi Li; Lujing Wang; David Cheng; Chao Wang; Rasika Hudlikar; Hsiao-Chen Kuo; Yaoping Lu; Ah-Ng Kong
Journal:  Mol Carcinog       Date:  2019-06-25       Impact factor: 4.784

5.  Effects of ablation and activation of Nrf2 on bile acid homeostasis in male mice.

Authors:  Youcai Zhang; Andrew J Lickteig; Jing Liu; Iván L Csanaky; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2020-07-29       Impact factor: 4.219

6.  Keap1 inhibition attenuates glomerulosclerosis.

Authors:  Yoichi Miyazaki; Akihiro Shimizu; Ira Pastan; Keiko Taguchi; Eriko Naganuma; Takafumi Suzuki; Tatsuo Hosoya; Takashi Yokoo; Akihiko Saito; Toshio Miyata; Masayuki Yamamoto; Taiji Matsusaka
Journal:  Nephrol Dial Transplant       Date:  2014-02-11       Impact factor: 5.992

7.  Nrf2 expression participates in growth and differentiation of endometrial carcinoma cells in vitro and in vivo.

Authors:  Kainan Li; Chen Zhong; Baocheng Wang; Jun He; Jingwang Bi
Journal:  J Mol Histol       Date:  2013-09-19       Impact factor: 2.611

Review 8.  Combating oxidative stress in diabetic complications with Nrf2 activators: how much is too much?

Authors:  Sih Min Tan; Judy B de Haan
Journal:  Redox Rep       Date:  2014-02-21       Impact factor: 4.412

9.  NRF2-mediated Notch pathway activation enhances hematopoietic reconstitution following myelosuppressive radiation.

Authors:  Jung-Hyun Kim; Rajesh K Thimmulappa; Vineet Kumar; Wanchang Cui; Sarvesh Kumar; Ponvijay Kombairaju; Hao Zhang; Joseph Margolick; William Matsui; Thomas Macvittie; Sanjay V Malhotra; Shyam Biswal
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

10.  Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils.

Authors:  Rajesh K Thimmulappa; Ralph J Fuchs; Deepti Malhotra; Catherine Scollick; Kassim Traore; Jay H Bream; Michael A Trush; Karen T Liby; Michael B Sporn; Thomas W Kensler; Shyam Biswal
Journal:  Antioxid Redox Signal       Date:  2007-11       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.